LEADER 00802nam0-2200241 --450 
001 9910309545103321
005 20190225125556.0
010   $a3805514719
100   $a20190225d1973----kmuy0itay5050----ba
101 0 $aeng
200 1 $aToxicological problems$fEditor: Ted A. Loomis
210   $aBasel$aNew York$cS. Karger$d1973
215   $axv, 242 p.$d25 cm
225 1 $aPharmacology and the future of man,$vv 2
300   $aIn testa al fontespizio: Proceedings of the Fifth  International Congress on Pharmacology, San Francisco, Calif., July 23-28, 1972
702  1$aLoomis,$bTed A.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a9910309545103321
952   $a80 FS XIV B 40.2$bBFA66/2019$fFFABC
959   $aFFABC
996   $aToxicological problems$91545951
997   $aUNINA

LEADER 02624nam  2200613 a 450 
001 9910462384903321
005 20200520144314.0
010   $a1-84973-474-7
035   $a(CKB)2670000000207120
035   $a(EBL)1185209
035   $a(OCoLC)798092373
035   $a(SSID)ssj0000734095
035   $a(PQKBManifestationID)12351249
035   $a(PQKBTitleCode)TC0000734095
035   $a(PQKBWorkID)10736565
035   $a(PQKB)11468339
035   $a(MiAaPQ)EBC1185209
035   $a(PPN)198470037
035   $a(Au-PeEL)EBL1185209
035   $a(CaPaEBR)ebr10627656
035   $a(CaONFJC)MIL871992
035   $a(EXLCZ)992670000000207120
100   $a20121208d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aBiomarkers for traumatic brain injury$b[electronic resource] /$fedited by Svetlana A. Dambinova, Ronald L. Hayes, Kevin K.W. Wang
210   $aCambridge [England] $cRSC Pub.$d2012
215   $a1 online resource (247 p.)
225  0$aRSC drug discovery series,$x2041-3203 ;$v24
300   $aDescription based upon print version of record.
311   $a1-84973-389-9 
320   $aIncludes bibliographical references and index.
327   $ai-iv; v-vi; vii-viii; ix-xvi; xvii-xx; 1-18; 19-44; 45-65; 66-86; 87-105; 106-121; 122-133; 134-147; 148-163; 164-175; 176-183; 184-199; 200-215; 216-226
330   $aDue to injuries sustained in sports and in combat, interest in TBI has never been greater. Biomarkers for Traumatic Brain Injury will fulfil a gap in our understanding of what is occurring in the brain following injury that can subsequently be detected in biological fluids and imaging. This knowledge will be useful for all researchers and clinicians interested in the biochemical and structural sequelae underpinning clinical manifestations of TBI and help guide appropriate patient management. Current and prospective biomarkers for the assessment of traumatic brain injury (TBI), particularly mil
410  0$aRSC Drug Discovery
606   $aBrain$xWounds and injuries
606   $aBiochemical markers
608   $aElectronic books.
615  0$aBrain$xWounds and injuries.
615  0$aBiochemical markers.
676   $a617.481044
701   $aDambinova$b Svetlana A$0884693
701   $aHayes$b Ronald L$0884694
701   $aWang$b Kevin K. W$0884695
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910462384903321
996   $aBiomarkers for traumatic brain injury$91975577
997   $aUNINA